Progress in research of sarcopenia in digestive system malignant tumors

doi:10.3877/cma.j.issn.1674-0785.2023.07.011

Abstract

Abstract:

More and more clinicians are realizing that the prognosis of cancer patients depends not only on tumor stage, pathological type, tumor cell differentiation, molecular type, etc., but also on patient factors, such as nutritional status. Compared to body mass index, patient muscle mass and physical function can more comprehensively reflect the patient's nutritional status. Previous studies have shown that sarcopenia can affect the prognosis of patients with gastrointestinal tumors and have an impact on different treatment modes. This state can be reversed through exercise, nutritional support, and medication treatment to improve the prognosis of patients.

Key words: Sarcopenia, Malignant digestive system tumors

Jiayuan Wang, Xiaodong Wang. Progress in research of sarcopenia in digestive system malignant tumors[J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(07): 823-827.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhlcyszz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0785.2023.07.011

https://zhlcyszz.cma-cmc.com.cn/EN/Y2023/V17/I07/823

References 53

1	Arnold M, Abnet CC, Neale RE, et al. Global burden of 5 major types of gastrointestinal cancer [J]. Gastroenterology, 2020, 159(1): 335-349. e15.
2	Muscaritoli M, Anker SD, Argilés J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics" [J]. Clin Nutr, 2010, 29: 154-159.
3	Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus [J]. Lancet Oncol, 2011, 12: 489-495.
4	Bowen TS, Schuler G, Adams V. Skeletal muscle wasting in cachexia and sarcopenia: molecularpathophysiology and impact of exercise training [J]. J Cachexia Sarcopenia Muscle, 2015, 6: 197-207.
5	Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on defifinition and diagnosis: report of the European Working Group on Sarcopenia in Older People [J]. Age Ageing, 2010, 39(4): 412-423.
6	Pamoukdjian F, Bouillet T, Levy V, et al. Prevalence and predictive value of pre-therapeutic sarcopenia in cancer patients: a systematic review [J]. Clin Nutr, 2018, 37: 1101-1113.
7	van Vugt JLA, Buettner S, Levolger S, et al. Low skeletal muscle mass is associated with increased hospital expenditure in patients undergoing cancer surgery of the alimentary tract [J]. PLoS One, 2017, 12: e0186547.
8	Sergi G, Trevisan C, Veronese N, et al. Imaging of sarcopenia [J]. Eur J Radiol, 2016, 85: 1519-1524.
9	Gomez-Perez SL, Haus JM, Sheean P, et al. Measuring abdominal circumference and skeletal muscle from a single cross-sectional computed tomography image: A step-by-step guide for clinicians using national institutes of health image J [J]. JPEN J Parenter Enteral Nutr, 2016, 40: 308-318.
10	Ní Bhuachalla ÉB, Daly LE, Power DG, et al. Computed tomography diagnosed cachexia and sarcopenia in 725 oncology patients: is nutritional screening capturing hidden malnutrition [J]? J Cachexia Sarcopenia Muscle, 2018, 9(2): 295-305.
11	Jogiat UM, Sasewich H, Turner SR, et al. Sarcopenia determined by skeletal muscle index predicts overall survival, disease-free survival, and postoperative complications in resectable esophageal cancer: A systematic review and meta-analysis [J]. Ann Surg, 2022, 276(5): e311-e318.
12	Mayanagi S, Ishikawa A, Matsui K, Matsuda S, Irino T, Nakamura R, et al. Association of preoperative sarcopenia with postoperative dysphagia in patients with thoracic esophageal cancer [J]. Dis Esophagus, 2021, 34(9): doaa121.
13	Ma BW, Chen XY, Fan SD, et al. Impact of sarcopenia on clinical outcomes after radical gastrectomy for patients without nutritional risk [J]. Nutrition, 2019, 61: 61-66.
14	Kawamura T, Makuuchi R, Tokunaga M, et al. Long-term outcomes of gastric cancer patients with preoperative sarcopenia [J]. Ann Surg Oncol, 2018, 25(6): 1625-1632.
15	Park SE, Hwang IG, Choi CH, et al. Sarcopenia is poor prognostic factor in older patients with locally advanced rectal can-cer who received preoperative or postoperative chemoradiotherapy [J]. Medicine (Balti-more), 2018, 97: e13363.
16	Miyamoto Y, Baba Y, Sakamoto Y, et al. Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer [J]. Ann Surg Oncol, 2015, 22: 2663-2668.
17	Papaconstantinou D, Vretakakou K, Paspala A, et al. The impact of preoperative sarcopenia on postoperative complications following esophagectomy for esophageal neoplasia: a systematic review and metaanalysis [J]. Dis Esophagus, 2020, 33: doaa002.
18	Nishigori T, Okabe H, Tanaka E, et al. Sarcopenia as a predictor of pulmonary complications after esophagectomy for thoracic esophageal cancer [J]. J Surg Oncol, 2016, 113: 678-684.
19	Kurita D, Oguma J, Ishiyama K, et al. Handgrip strength predicts postoperative pneumonia after thoracoscopic-laparoscopic esophagectomy for patients with esophageal cancer [J]. Ann Surg Oncol, 2020, 37: 3173-3181.
20	Huang DD, Wang SL, Zhuang CL, et al. Sarcopenia, as defined by low muscle mass, strength and physical performance, predicts complications after surgery for colorectal cancer [J]. Colorectal Dis, 2015, 17: O256-O264.
21	Peng P, Hyder O, Firoozmand A, et al. Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma [J]. J Gastrointest Surg, 2012, 16: 1478-1486.
22	Kodera Y. More than 6 months of postoperative adjuvant chemotherapy results in loss of skeletal muscle: a challenge to the current standard of care [J]. Gastric Cancer, 2015, 18: 203-204.
23	Li YP, Reid MB. Effect of tumor necrosis factor-alpha on skeletal muscle metabolism [J]. Curr Opin Rheumatol, 2001, 13: 483-487.
24	Gilliam LA, Moylan JS, Ferreira LF, et al. TNF/TNFR1 signaling mediates doxorubicin-induced diaphragm weakness [J]. Am J Physiol Lung Cell Mol Physiol, 2011, 300: L225-31.
25	Gilliam LA, Moylan JS, Callahan LA, et al. Doxorubicin causes diaphragm weakness in murine models of cancer chemotherapy [J]. Muscle Nerve, 2011, 43: 94-102.
26	Chen JL, Colgan TD, Walton KL, et al. The TGF-beta signalling network in muscle development, adaptation and disease [J]. Adv Exp Med Biol, 2016, 900: 97-131.
27	Ramesh G, Reeves WB. TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity [J]. J Clin Invest, 2002, 110: 835-842.
28	Ederer AK, Didier KD, Reiter LK, et al. Influence of adjuvant therapy in cancer survivors on endothelial function and skeletal muscle deoxygenation [J]. PLoS One, 2016, 11: e0147691.
29	Daly LE, Ni Bhuachalla EB, Power DG, et al. Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer [J]. J Cachexia Sarcopenia Muscle, 2018, 9: 315-325.
30	Barreiro E, Gea J. PARP-1 and PARP-2 activity in cancer induced cachexia: potential therapeutic implications [J]. Biol Chem, 2018, 399: 179-186.
31	Mohamed JS, Wilson JC, Myers MJ, et al. Dysregulation of SIRT-1 in aging mice increases skeletal muscle fatigue by a PARP-1-dependent mechanism [J]. Aging (Albany NY), 2014, 6: 820-834.
32	Pirinen E, Canto C, Jo YS, et al. Pharmacological Inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle [J]. Cell Metab, 2014, 19: 1034-1041.
33	Toledo M, Penna F, Oliva F, et al. A multifactorial anticachectic approach for cancer cachexia in a rat model undergoing chemotherapy [J]. J Cachexia Sarcopenia Muscle, 2016, 7: 48-59.
34	Catikkas NM, Bahat Z, Oren MM, et al. Older cancer patients receiving radiotherapy: a systematic review for the role of sarcopenia in treatment outcomes [J]. Aging Clin Exp Res, 2022, 34(8): 1747-1759.
35	Lutz CT, Quinn LS. Sarcopenia, obesity, and natural killer cell immune senescence in aging: altered cytokine levels as a common mechanism [J]. Aging, 2012, 4, 535-546.
36	Girard D, Paquet ME, Paquin R, et al. Differential effects of interleukin-15 (IL-15) and IL-2 on human neutrophils: modulation of phagocytosis, cytoskeleton rearrangement, gene expression, and apoptosis by IL-15 [J]. Blood, 1996, 88(8): 3176-3184
37	Nelke C, Dziewas R, Minnerup J, et al. Skeletal muscle as potential central link between sarcopenia and immune senescence [J]. EBioMedicine, 2019, 49: 381-388.
38	Haddad F, Zaldivar F, Cooper DM, et al. IL-6-induced skeletal muscle atrophy [J]. J Appl Physiol (1985), 2005, 98(3): 911-917.
39	Akce M, Liu Y, Zakka K, et al. Impact of Sarcopenia, BMI, and inflflammatory biomarkers on survival in advanced hepatocellular carcinoma treated with anti-Pd-1 antibody [J]. Am J Clin Oncol, 2021, 44(2): 74-81.
40	Xiao LS, Li RN, Cui H, et al. Use of computed tomography-derived body composition to determine the prognosis of patients with primary liver cancer treated with immune checkpoint inhibitors: A retrospective cohort study [J]. BMC Cancer, 2022, 22(1): 737.
41	Fujii H, Makiyama A, Iihara H, et al. Cancer cachexia reduces the effificacy of nivolumab treatment in patients with advanced gastric cancer [J]. Anticancer Res, 2020, 40, 7067-7075.
42	Kano M, Hihara J, Tokumoto N, et al. Association between skeletal muscle loss and the response to nivolumab immunotherapy in advanced gastric cancer patients [J]. Int J Clin Oncol, 2021, 26, 523-531.
43	Prado CM, Lieffers JR, Bowthorpe L, et al. Sarcopenia and physical function in overweight patients with advanced cancer [J]. Can J Diet Pract Res, 2013, 74: 69-74.
44	Moro T, Brightwell CR, Deer RR, et al. Muscle protein anabolic resistance to essential amino acids does not occur in healthy older adults before or after resistance exercise training [J]. J Nutr, 2018, 148: 900-909.
45	Volpi E, Kobayashi H, Sheffield-Moore M, et al. Essential amino acids are primarily responsible for the amino acid stimulation of muscle protein anabolism in healthy elderly adults [J]. Am J Clin Nutr, 2003, 78: 250-258.
46	Paddon-Jones D, Campbell WW, Jacques PF, et al. Protein and healthy aging [J]. Am J Clin Nutr, 2015, 101: 1339s-1345s.
47	van der Wielen RP, Lowik MR, van den Berg H, et al. Serum vitamin D concentrations among elderly people in Europe [J]. Lancet, 1995, 346: 207-210.
48	Morley JE, Argiles JM, Evans WJ, et al. Nutritional recommendations for the management of sarcopenia [J]. J Am Med Dir Assoc, 2010, 11: 391-396.
49	Rolland Y, Dupuy C, Abellan van Kan G, et al. Treatment strategies for sarcopenia and frailty [J]. Med Clin North Am, 2011, 95(3): 427-348, ix.
50	Murphy RA, Mourtzakis M, Chu QS, et al. Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer [J]. Cancer, 2011, 117: 3774-3780.
51	Vallejo J, Spence M, Cheng AL, et al. Cellular and physiological effects of dietary supplementation with beta-Hydroxy-beta-Methylbutyrate (HMB) and beta-Alanine in late middle-aged mice [J]. PLoS One, 2016, 11: e0150066.
52	Alway SE, Pereira SL, Edens NK, et al. beta-Hydroxy beta-methylbutyrate (HMB) enhances the proliferation of satellite cells in fast muscles of aged rats during recovery from disuse atrophy [J]. Exp Gerontol, 2013, 48: 973-984.
53	Stout JR, Smith-Ryan AE, Fukuda DH, et al. Effect of calcium beta-hydroxy-beta-methylbutyrate (CaHMB) with and without resistance training in men and women 65+yrs:a randomized, double-blind pilot trial [J]. Exp Gerontol, 2013, 48: 1303-1310.

[1]	Fangming Yao, Yingying Jiao, Mincong He, Zijun Zeng, Xiaoming He, Liangyan Liu, Wei He, Qiushi Wei, Wengang Liu. Incidence and analysis of characteristics of sarcopenia in patients with knee osteoarthritis [J]. Chinese Journal of Joint Surgery(Electronic Edition), 2024, 18(01): 30-38.
[2]	Jindong Ma, Lei Wang, Tingting Cai, Xiangfei Jiao, Qiangpu Chen. Current status and influencing factors of sarcopenia in abdominal surgery inpatients [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(01): 69-74.
[3]	Caiyan Gao, Shuze Zhang, Hongtai Cao, Hanteng Yang, Jie Mao. Advances in the study of sarcopenia among patients with gastric cancer [J]. Chinese Archives of General Surgery(Electronic Edition), 2022, 16(04): 302-307.
[4]	Ling Xi, Hanwen Tong, Ji Miao, Yonghuan Mao, Xiaofei Shen, Junfeng Du, Ye Liu. Risk factors prediction model of parastostomy hernia based on sarcopenia [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(01): 48-51.
[5]	Zun Chen, Ping Wang, Hua Jin, Meiling Zhou, Qingqing Li, Yonggang Huang. Application of sarcopenia in predicting incisional hernia after colorectal cancer surgery [J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2024, 18(06): 639-644.
[6]	Ning Wang, Yanzhe Liu, Ziying Wu, Chao Zeng, Guanghua Lei, Tingting Sha, Yilun Wang. Causal associations of gut Microbiota with phenotype indicators of sarcopenia: A mendelian randomization study [J]. Chinese Journal of Geriatric Orthopaedics and Rehabilitation(Electronic Edition), 2023, 09(06): 333-342.
[7]	Chunfeng Liu, Zhaohui Xu, Hongwei Shi, Rong Chen, Tengfei Ma, Pengfei Li, Rong Yuan, Jianrong Chen, Aiming Xu. Diagnosis of sarcopenia in mechanically ventilated patients and its impact on prognosis [J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(09): 820-825.
[8]	Peipei Xi, Jiajun Zhou. Progress in research of sarcopenia in patients with chronic kidney disease: pathogenesis, diagnosis, and treatment [J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(05): 491-495.
[9]	Jingdong Ma, Xiangfei Jiao, Tingting Cai, Qiangpu Chen. Research progress of sarcopenia and liver cancer [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(03): 356-359.
[10]	Jingran Cao, Fuqiang Dong, Lijian Zhang, Changle Liu, Yukun Zhang, Kangyin Chen. Screening of nutritional risk, sarcopenia and frailty in older inpatients with coronary heart disease [J]. Chinese Journal of Geriatrics Research(Electronic Edition), 2024, 11(02): 5-9.
[11]	Juan Cao, Ya Zhu, Yuquan Wu, Xugang Hu, Fang Dong, Yilian Hong, Ying Gui. The predictive value of modified Morse scale for falls risk in elderly inpatients [J]. Chinese Journal of Geriatrics Research(Electronic Edition), 2024, 11(02): 1-4.
[12]	Huilan Guan, Jingmei Zhang, Yanhong Xie. Investigation in the awareness of sarcopenia knowledge among community elderly patients [J]. Chinese Journal of Geriatrics Research(Electronic Edition), 2024, 11(02): 36-43.
[13]	Jiawei Chen, Zeyun Li, Le Xiao, Jianwen Chen, Jiling Liang, Jingtao Zhou. Prevalence and risk factors of sarcopenia in the elderly in China: A meta-analysis [J]. Chinese Journal of Geriatrics Research(Electronic Edition), 2022, 09(04): 40-45.
[14]	Chaojun Wang, Zhiyong Dong, Wan'e Zhao, Songhao Hu, Zhaohui Liu. Influence of sarcopenia on the effect of sleeve gastrectomy in patients with obesity [J]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2024, 10(04): 283-287.
[15]	Chaojun Wang, Zhaohui Liu. Progress in diagnosis and treatment of sarcopenic obesity [J]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2024, 10(04): 269-275.

Please choose a citation manager

Content to export